SG Americas Securities
MANE

SG Americas Securities’s Veradermics Inc MANE Stock Holding History

SG Americas Securities’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34M Buy
+35,266
New +$3.3M ﹤0.01% 1156

Other funds holding MANE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return

SG Americas Securities's MANE Position: Q2 2026 in Review

SG Americas Securities opened a new position in Veradermics Inc (MANE) in Q2 2026: 35,266 shares worth $4.34M. The stake represents ﹤0.01% of the portfolio and ranks #1156 among its holdings.

47 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • SG Americas Securities held 35,266 shares of Veradermics Inc worth $4.34M as of Q2 2026.
  • Veradermics Inc was a new SG Americas Securities position in Q2 2026.
  • Veradermics Inc made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1156 holding.
  • 47 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.